Semble has raised £30 million in a Series C funding round led by Revaia, with participation from Partech and existing investors Mercia Ventures and Octopus Ventures.
Semble is a UK-based healthcare technology company that provides a practice management and care coordination platform for outpatient healthcare providers. Its software helps clinicians, medical practices, and healthcare organisations manage patient journeys, coordinate care, and streamline clinical and administrative workflows through a unified platform.
The company says more than 10 million patients have received care through clinicians using its platform. Semble also serves more than 1,700 healthcare organisations, including Nuffield Health, Welbeck, Midland Health, London Doctors Clinic, Modality, and ProblemShared.
According to the company, adoption has increased among private outpatient hospitals and healthcare groups seeking to consolidate multiple operational systems into a single platform.
Commenting on the funding, CEO and co-founder Christoph Lippuner said that healthcare providers have traditionally relied on disconnected technology solutions to address operational challenges, a fragmented approach that can increase complexity for providers and create a less seamless experience for patients:
What healthcare organisations need is intelligent orchestration across the entire care journey. The practices and groups that win over the next decade will be the ones that deliver the best patient experience end-to-end. This investment allows us to rapidly scale that vision across the UK and Europe.
Semble plans to use the funding to expand its presence among large healthcare groups, strengthen its position in the UK and France, and further develop its AI-powered care orchestration capabilities.
Would you like to write the first comment?
Login to post comments